Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb;43(2):126-130.
doi: 10.1055/s-0040-1721857. Epub 2021 Jan 19.

The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial

Mahboobeh Shirazi  1   2 , Mohamad Naser Jalalian  2 , Masoumeh Abed  3 , Marjan Ghaemi  4
Affiliations
Randomized Controlled Trial

The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial

Mahboobeh Shirazi et al. Rev Bras Ginecol Obstet. 2021 Feb.

Abstract

Objective: The present study aimed to assess the effect of Melissa Officinalis L. (a combination of lemon balm with fennel fruit extract) compared with citalopram and placebo on the quality of life of postmenopausal women with sleep disturbance.

Methods: The present study is a randomized, double-blind, placebo clinical trial among 60 postmenopausal women with sleep disturbance who were referred to a university hospital from 2017 to 2019. The participants were randomized to receive M. Officinalis L. (500 mg daily), citalopram (30 mg) or placebo once daily for 8 weeks. The Menopause-Specific Quality of Life (MENQOL) questionnaire was self-completed by each participant at baseline and after 8 weeks of the intervention and was compared between groups.

Results: The mean for all MENQOL domain scores were significantly improved in the M. Officinalis L. group compared with citalopram and placebo (p < 0.001). The mean ± standard deviation (SD) after 8 weeks in the M. Officinalis L., citalopram and placebo groups was 2.2 ± 0.84 versus 0.56 ± 0.58 versus 0.36 ± 0.55 in the vasomotor (p < 0.001), 1.02 ± 0.6 versus 0.28 ± 0.2 versus 0.17 ± 0.1 in the psychomotor-social (p < 0.001), 0.76 ± 0.4 versus 0.25 ± 0.1 versus 0.11 ± 0.1 in the physical and 2.3 ± 1.0 versus 0.35 ± 0.5 versus 0.41 ± 0.5 in the sexual domain, respectively.

Conclusions: The results revealed that M. Officinalis L. may be recommended for improving the quality of life of menopausal women with sleep disturbance.

Trial registration: The present study was registered by the name "Comparison of the efficacy of citalopram and compound of Asperugo procumbens and foeniculum vulgare in treatment of menopausal disorders" with the code IRCT2013072714174N1 in the Iranian Registry of Clinical Trials (IRCT).

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests to declare.

Similar articles

See all similar articles

Cited by

References

    1. Greendale G A, Lee N P, Arriola E R.The menopause Lancet 1999353(9152):571–580.10.1016/S0140-6736(98)0552-5 - DOI - PubMed
    1. Gibbs R S, Karlan B Y, Haney A F, Nygaard I E. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. Danforth's obstetrics and gynecology.
    1. Freedman R R. Menopause and sleep. Menopause. 2014;21(05):534–535. doi: 10.1097/GME.0000000000000243. - DOI - PubMed
    1. Krystal A D, Edinger J, Wohlgemuth W, Marsh G R. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 1998;2(04):243–253. doi: 10.1016/s1087-0792(98)90011-9. - DOI - PubMed
    1. Baker F C, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin. 2018;13(03):443–456. doi: 10.1016/j.jsmc.2018.04.011. - DOI - PMC - PubMed

Publication types

MeSH terms